MoonLake Immunotherapeutics

NASDAQ:MLTX

46.88 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 271.566180.426375.656342.791458.441451.169318.166501.78750.12939.50641.20592.708101.0238.0391.0291.0981.170
Short Term Investments 208.564267.601118.268177.00888.61459.839177.813012.92132.60942.25500000115.0150
Cash and Short Term Investments 480.13448.027493.925519.8547.055511.008495.979501.78763.0572.11583.45992.708101.0238.0391.0291.0981.170
Net Receivables 2.9882.8432.4071.6771.4961.0570.7210.620.3780.2170.6010.557150.1490000
Inventory 000000000000000000
Other Current Assets 23.14623.41815.98415.4065.0392.1023.313.963.0764.1794.4790.0780.1360.1270.0440.2340.290
Total Current Assets 506.264474.289512.316536.882553.59514.167500.01506.36766.50476.51188.53998.378116.1599.6371.2071.3311.460
Non-Current Assets:
Property, Plant & Equipment, Net 3.33.6443.8333.8674.2083.9490.2090.2540.2920.3320.0530.0560.0590.0460.03000
Goodwill 000000000000000000
Intangible Assets 000000000000000000
Goodwill and Intangible Assets 000000000000000000
Long Term Investments 000000000000115.051115.043115.04115.039115.0330
Tax Assets 000000000000000000
Other Non-Current Assets 1.69802.0654.1296.3198.423000000-0.059-115.043-0.03000
Total Non-Current Assets 4.9983.6445.8977.99610.52712.3730.2090.2540.2920.3320.0530.056115.0510.046115.04115.039115.0330
Total Assets 511.262477.933518.213544.878564.117526.54500.219506.62166.79776.84388.59298.434231.219.682116.247116.37116.4920
Liabilities & Equity:
Current Liabilities:
Account Payables 08.6780.1040.0561.630.5530.8240.2710.5110.0660.1560.2470.2131.2330.096000
Short Term Debt 1.4321.3721.7522.6431.3041.3060.1560.3160.310.1540015.15150000
Tax Payables 00.6420.4840.6190.8510.3682.71400.2010.110.0621.55900.0640000
Deferred Revenue 0000.563-0.778-0.1850-0.2710000-0.21300000
Other Current Liabilities 22.54922,453.16917.748.9645.1257.7386.6146.5476.2577.3365.8022.051187.4274.7911.9630.090.060
Total Current Liabilities 23.98122,463.86120.08112.2828.9119.96610.3087.1357.2797.6656.0193.857202.7921.0882.0590.090.060
Non-Current Liabilities:
Long Term Debt 74.1641.4581.9362.0222.3572.50.0130.0530.0910.12900000000
Deferred Revenue Non-Current 000000000000000000
Deferred Tax Liabilities Non-Current 000000000000000000
Other Non-Current Liabilities 0.5360.6210.6950.5420.4630.5830.2550.3240.3140.2820.0050.0194.0250.244.0254.0254.0250
Total Non-Current Liabilities 74.72,078.2822.6312.5642.823.0830.2680.3770.4050.4110.0050.0194.0250.244.0254.0254.0250
Total Liabilities 98.68124,542.14322.71214.84611.73113.04910.5777.5117.6858.0776.0243.876206.81521.3276.0844.1154.0850
Equity:
Preferred Stock 0000000000000.0720.0720.072000
Common Stock 0.0060.0060.0060.0060.0060.0060.0060.0060.0050.0050.0050.0050.0010.039115107.255107.4080
Retained Earnings -275.537-235,592.989-189.988-154.598-130.331-116.657-109.22-99.794-89.655-80.65-68.788-58.678-9.763-53.644-4.837-0.319-0.1670
Accumulated Other Comprehensive Income/Loss 2.3874.9972.8343.2572.6932.3582.8750.0350.340.3510.2450.1340.098-0.1680000
Other Total Stockholders Equity 680.664682,412.988675.343671.999670.185609.969531.272589.55131.309129.192123.826122.05434.15742.05605.3195.1670
Total Shareholders Equity 407.52446,825.002488.195520.664542.554495.676424.933489.79741.99948.89855.28863.51524.395-11.645110.163112.255112.4070
Total Equity 0453.391495.502530.031552.386513.491489.642499.1159.11268.76782.56894.55824.395-11.645110.163112.255112.4070
Total Liabilities & Shareholders Equity 511.262477.933518.213544.878564.117526.54500.219506.62166.79776.84388.59298.434231.219.682116.247116.37116.4920